Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade F 6.59 -5.72% -0.40
AMRN closed down 5.72 percent on Tuesday, August 11, 2020, on 1.12 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Aug 19
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical AMRN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
Calm After Storm Range Contraction -5.72%
Upper Bollinger Band Walk Strength -5.72%
Upper Bollinger Band Touch Strength -5.72%
Shooting Star Candlestick Bearish -5.86%
Lizard Bearish Bearish Day Trade Setup -5.86%
Calm After Storm Range Contraction -5.86%
Doji - Bearish? Reversal -5.86%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Lipids Low Density Lipoprotein Hypertriglyceridemia Saturated Fat

Is AMRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.12
52 Week Low 3.95
Average Volume 5,956,152
200-Day Moving Average 12.98
50-Day Moving Average 6.79
20-Day Moving Average 6.71
10-Day Moving Average 6.78
Average True Range 0.36
ADX 20.83
+DI 23.69
-DI 14.60
Chandelier Exit (Long, 3 ATRs ) 6.29
Chandelier Exit (Short, 3 ATRs ) 7.38
Upper Bollinger Band 7.10
Lower Bollinger Band 6.33
Percent B (%b) 0.34
BandWidth 11.55
MACD Line 0.02
MACD Signal Line -0.02
MACD Histogram 0.0339
Fundamentals Value
Market Cap 1.78 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -21.26
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.28
Resistance 3 (R3) 7.35 7.20 7.17
Resistance 2 (R2) 7.20 7.02 7.16 7.13
Resistance 1 (R1) 6.89 6.91 6.82 6.82 7.09
Pivot Point 6.74 6.74 6.70 6.70 6.74
Support 1 (S1) 6.43 6.56 6.36 6.36 6.09
Support 2 (S2) 6.28 6.45 6.24 6.05
Support 3 (S3) 5.97 6.28 6.02
Support 4 (S4) 5.90